Structure of (R)-Lansoprazole
CAS No.: 138530-94-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
(R)-Lansoprazole, the dextrorotatory enantiomer of lansoprazole, can irreversibly inactivate the H+/K+-stimulated ATPase pump.
Synonyms: Dexlansoprazole; T-168390; TAK-390
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 138530-94-6 |
Formula : | C16H14F3N3O2S |
M.W : | 369.36 |
SMILES Code : | O=[S@@](C1=NC2=CC=CC=C2N1)CC3=NC=CC(OCC(F)(F)F)=C3C |
Synonyms : |
Dexlansoprazole; T-168390; TAK-390
|
MDL No. : | MFCD13196699 |
InChI Key : | MJIHNNLFOKEZEW-RUZDIDTESA-N |
Pubchem ID : | 9578005 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Description |
(R)-Lansoprazole is the R enantiomer of Lansoprazole. Lansoprazole (AG 1749) is an orally active proton pump inhibitor that suppresses gastric acid production. Additionally, Lansoprazole (AG 1749) is a potent brain-penetrating inhibitor of neutral sphingomyelinase (N-SMase), which also acts as an exosome inhibitor[1][2].
|
Target |
|
In Vitro:
Concentration | Treated Time | Description | References |
RAW 264.7 cells | 1-2.5 μM | 4 days | increased the proportion of large osteoclasts | PMC4703748 |
HEK293 cells | 20 μM | 30 min | enhances polyubiquitination of the TNF receptor-associated factor 6 (TRAF6) | PMC4703748 |
human osteoblastic osteosarcoma (HOS) cells | 20 μM | 2 days | enhanced intranuclear accumulation of Runx2 | PMC4703748 |
mouse pluripotent mesenchymal C3H10T1/2 cells | 20 μM | 1 day | increased the RUNX2 P1 promoter activity | PMC4703748 |
human mesenchymal stromal cells | 20 μM | 2 days | enhances nuclear accumulation of Runx2 and induces osteoblastogenesis | PMC4703748 |
Candida auris AR0390 | 16 µM/mL | 24 h | Screening FDA-approved drugs to enhance the antifungal activity of AmB, LNP at 16 µM/mL combined with 0.125×MIC of AmB inhibited 90% of C. auris growth. | PMC10911247 |
CCF astrocytoma cells | 20 μM | 48 h | To test the effect of Lansoprazole on ABCA1 and Apo-E protein levels, results showed significant increases in intracellular ABCA1 and Apo-E protein levels. | PMC2834822 |
H4 neuroglioma cells | 20 μM | 24 h | To test the effect of Lansoprazole and its structural analogs on ABCA1 mRNA expression, results showed that Lansoprazole and Pantoprazole significantly upregulated ABCA1 mRNA expression. | PMC2834822 |
Cos-7 cells | 0.1 μM to 50 μM | 16-20 h | To validate whether Lansoprazole can activate LXR, results showed that 5 and 10 μM of Lansoprazole had a maximum response of 2-fold increase for LXR α and 3-fold increase for LXR β. | PMC2834822 |
A549 cells | 25, 50, 100, 200 μM | 48 h | Lpz induced apoptosis and G0/G1 cell cycle arrest by inhibiting the activation of Stat3, PI3K/Akt, and Raf/ERK pathways. Additionally, Lpz inhibited autophagy by blocking the fusion of autophagosomes with lysosomes. | PMC8093516 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Sprague–Dawley (SD) rats | Femoral fracture model | Oral | 7.5 mg/kg | Once daily for 4 weeks | Increased osteoblastogenesis and accelerated fracture healing | PMC4703748 |
CD-1 mice | Disseminated C. auris infection model | Oral | 300 mg/kg | Once daily for two days | Evaluating the efficacy of the AmB/LNP combination in a disseminated C. auris infection model, results showed a 1.7-log (98%) reduction in fungal burden in the kidneys. | PMC10911247 |
Male albino Wistar rats | Indomethacin-induced gastric ulcer model | Oral | 30 mg/kg | Once daily for 14 days | To evaluate the protective effect of (R)-Lansoprazole against indomethacin-induced gastric ulcer, results showed that Lansoprazole significantly reduced the ulcer index, increased gastric mucin content, and improved antioxidant biomarkers. | PMC8540802 |
BALB/c nude mice | A549 nude mouse xenograft model | Oral | 25 mg/kg | Every other day for 19 days | Lpz alone or in combination with Gef significantly attenuated the growth of A549 nude mouse xenograft models. | PMC8093516 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00274339 | Laryngopharyngeal Reflux | Not Applicable | Unknown | June 2008 | United States, Kentucky ... More >> Commonwealth Ear, Nose & Throat Recruiting Louisville, Kentucky, United States, 40207 Contact: Marti Gardner, MSN 502-893-0159 ext 1185 mgardner@commonwealthent.com Principal Investigator: Kenneth M Hodge, MD Sub-Investigator: John R Morris, MD Sub-Investigator: Donald V Welsh, MD Sub-Investigator: Gorden T McMurry, MD Sub-Investigator: Andrew R Gould, MD Sub-Investigator: Keith D Forwith, PhD, MD Sub-Investigator: Steven D Shotts, MD Sub-Investigator: Tamalynn O'Daniel, MSN, ARNP Sub-Investigator: Jolene H Boswell, PA-C Sub-Investigator: Mary S McLaughlin, PA-C Sub-Investigator: Martha L Gardner, MSN, ARNP Sub-Investigator: Brian Walker, PA-C Less << |
NCT02297126 | Adverse Drug Reaction | Not Applicable | Completed | - | United States, Indiana ... More >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 Less << |
NCT00237679 | Voice Disorders ... More >> Gastroesophageal Reflux Less << | Not Applicable | Terminated(Terminated due to f... More >>unding loss.) Less << | - | United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less << |
NCT01922505 | - | Completed | - | Korea, Republic of ... More >> Seoul National University Bundang Hospital Bundang-gu, Seongnam, Gyeonggi-do, Korea, Republic of, 463-707 Less << | |
NCT02442752 | Pediatric Gastroesophageal Ref... More >>lux Disease Less << | PHASE1 | WITHDRAWN | 2025-12-23 | Children's Hospital Los Angele... More >>s, Los Angeles, California, 90027, United States|University of Louisville, Louisville, Kentucky, 40202, United States|Johns Hopkins University School Of Medicine, Baltimore, Maryland, 21218, United States|Michigan Pediatric GI Center, Flint, Michigan, 48532, United States|Promedica Toledo Children's Hospital, Toledo, Ohio, 43606, United States|Cook Children's Medical Center, Fort Worth, Texas, 76104, United States|Hadassah University Hospital - Ein Kerem, Jerusalem, 9112001, Israel|Schneider Children's Medical Center, Petach-Tikva, 4920235, Israel|Sheba Medical Center, Ramat Gan, 5262000, Israel|Assaf Harofeh M.C, Rishon Lezion, 75309, Israel|Azienda Ospedaliera Universitaria "Federico II", Napoli, 80131, Italy|Umberto I Pol. di Roma-Universita di Roma La Sapienza, Roma, 00161, Italy|Ospedale Pediatrico Bambino Gesu, Roma, 00165, Italy|Policlinico Universitario Agostino Gemelli, Roma, 00168, Italy|Centro de Investigacion Clinica Acelerada, S.C., Mexico, Distrito Federal, 07020, Mexico|Centro de Investigacion Clinica Chapultepec S.A. de C.V., Morelia, Michoacan, 58260, Mexico|Accelerium S. de R.L. de C.V., Monterrey, Nuevo Leon, 64000, Mexico|Szpital Uniwersytecki nr 2 im.dr J. Biziela, Bydgoszcz, 85-168, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, 30-663, Poland|Uniwersytecki Szpital Dzieciecy w Lublinie, Lublin, 20-093, Poland|Szpital Wojewodzki nr 2 w Rzeszowie, Rzeszow, 35-301, Poland|Instytut "Pomnik - Centrum Zdrowia Dziecka", Warszawa, 04-730, Poland Less << |
NCT03050359 | Duodenal Ulcer | Phase 3 | Recruiting | June 7, 2019 | - |
NCT01129713 | Gastroesophageal Reflux Diseas... More >>e (GERD) Heartburn Indigestion Less << | Phase 1 Phase 2 | Unknown | May 2015 | United States, Arizona ... More >> Southern Arizona Veterans Health Care System Recruiting Tucson, Arizona, United States, 85723 Principal Investigator: Ronnie Fass, MD Less << |
NCT00738543 | Healthy Volunteers | Phase 3 | Completed | - | Mexico ... More >> University of Guanajuato School of Medicine Leon, Guanajuato, Mexico, 37000 Less << |
NCT02615184 | Erosive Esophagitis | PHASE2 | RECRUITING | 2027-10-31 | University of South Alabama, M... More >>obile, Alabama, 36604, United States|University of California San Francisco, San Francisco, California, 94158, United States|D&H National Research Centers, Miami, Florida, 33155, United States|Children's Center for Digestive Health Care, LLC, Atlanta, Georgia, 30342, United States|Gastrointestinal Associates, PA, Flowood, Mississippi, 39232, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Measurable Outcome Research, Oklahoma City, Oklahoma, 73112, United States|GI for Kids, Knoxville, Tennessee, 37922, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37212, United States|Envision Clinical Research, LLC, Laredo, Texas, 78041, United States|The Children's Hospital of The King's Daughters, Norfolk, Virginia, 23507, United States|Women and Children's Health Research Institute, Edmonton, Alberta, T6G 1C9, Canada|London Health Sciences Centre (LHSC) - Children's Hospital, London, Ontario, N6A 5W9, Canada|Hospital Universitario San Ignacio, Bogota, 110231, Colombia|Fundacion Valle del Lili, Cali, 760032, Colombia|Centro Medico Imbanaco de Cali S.A, Cali, 760042, Colombia|Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, LT-50161, Lithuania|Children's Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Public Institution, Vilnius, LT-08661, Lithuania|Boca Clinical Trials Mexico SC, Colonia Las Americas, Distrito Federal, 1120, Mexico|Clinical Research Institute S.C., Tlalnepantla, Estado De Mexico, 54055, Mexico|Inspirepharma S. de R.L. de C.V., Monterrey, Nuevo Leon, 64660, Mexico|El Cielo Medical Center, Puebla, 72160, Mexico|SMIQ S. de R.L. de C.V., Queretaro, 76070, Mexico|In Vivo Osrodek Badan Klinicznych, Bydgoszcz, Kuyavia, 85-048, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Malopolskie, 30-663, Poland|Instytut "Pomnik - Centrum Zdrowia Dziecka", Warszawa, Masovia, 04-730, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Podkarpackie, 35-302, Poland Less << |
NCT00762359 | Stomach Ulcer ... More >> Duodenal Ulcer Less << | Phase 3 | Terminated(AG-1749 superior to... More >> Gefarnate in ulcer prevention) Less << | - | - |
NCT01321125 | Infectious Diseases | Phase 3 | Completed | - | Mexico ... More >> University of Guanajuato School of Medicine Leon, Guanajuato, Mexico, 37000 Less << |
NCT00787254 | Stomach Ulcer ... More >> Duodenal Ulcer Less << | Phase 3 | Completed | - | - |
NCT00762359 | - | Terminated(AG-1749 superior to... More >> Gefarnate in ulcer prevention) Less << | - | - | |
NCT00738543 | - | Completed | - | - | |
NCT00787254 | - | Completed | - | - | |
NCT02099708 | - | Completed | - | - | |
NCT02099708 | - | Completed | - | - | |
NCT03050307 | Gastric Ulcer ... More >> Peptic Ulcer Gastrointestinal Diseases Digestive System Diseases Lansoprazole Anti-Ulcer Agents Gastrointestinal Agents Proton Pump Inhibitors Enzyme Inhibitors Molecular Mechanisms of Pharmacological Action Less << | Phase 3 | Recruiting | April 19, 2019 | - |
NCT02099682 | - | Completed | - | - | |
NCT02151786 | - | Completed | - | - | |
NCT01131026 | Helicobacter Pylori Infection | Phase 3 | Completed | - | Turkey ... More >> Erciyes University School of Medicine Hospital, Department of Internal Medicine and Gastroenterology Kayseri, Turkey, 38039 Less << |
NCT02170207 | - | Completed | - | - | |
NCT02151786 | - | Completed | - | - | |
NCT02170207 | - | Completed | - | - | |
NCT01990339 | - | Completed | - | - | |
NCT02703896 | Pulmonary Aspiration of Gastri... More >>c Contents Less << | Phase 4 | Completed | - | - |
NCT02099682 | - | Completed | - | - | |
NCT03488173 | Effect of Drugs ... More >> Safety Issues Less << | Phase 1 | Recruiting | October 2018 | China, Zhejiang ... More >> First affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Lihua Wu, Doctor 86 571 87236560 lihuawu73@163.com Contact: Jian Liu, Master 86 571 87236560 lindaliu87@163.com Principal Investigator: Lihua Wu Principal Investigator: Jian Liu Less << |
NCT03043521 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less << |
NCT01990339 | - | Completed | - | - | |
NCT01762657 | Type 1 Diabetes | Phase 3 | Withdrawn(Study stopped prior ... More >>to Patient Enrollment) Less << | September 2015 | - |
NCT03079050 | GERD Proton P... More >>ump Inhibitor Less << | Phase 4 | Completed | - | Lebanon ... More >> American University of Beirut - Medical Center Beirut, Lebanon Less << |
NCT03355170 | GERD Cardiac ... More >>Event Safety Issues Less << | Phase 4 | Not yet recruiting | January 1, 2019 | Turkey ... More >> Başkent University Hospital Gastroenterology Dep. Not yet recruiting Adana, Turkey Contact: Birol Özer, Prof Dr birolozer@yahoo.com Çukurova University Medical Faculty Cardiology Dep. Not yet recruiting Adana, Turkey Contact: Mesut Demir, Prof Dr mdemir46@hotmail.com Ankara University Medical Faculty Gastroenterology Dep. Not yet recruiting Ankara, Turkey Contact: Mehmet Bektaş, Prof Dr Mehmet.Bektas@medicine.ankara.edu.tr Dışkapı Research and Training Hospital Gastroenterology Dep. Not yet recruiting Ankara, Turkey Contact: Elife Erarslan, Assoc Prof Dr elifeerarslan@gmail.com Yüksek İhtisas Research and Training Hospital Gastroenterology Dep. Not yet recruiting Ankara, Turkey Contact: İsmail Hakkı Kalkan, Assoc Prof Dr drismailster@gmail.com Antalya Research and Training Hospital Gastroenterology Dep. Not yet recruiting Antalya, Turkey Contact: Ayhan Hilmi Çekin, Assoc Prof Dr ayhancekin@hotmail.com Balıkesir University Medical Faculty Gastroenterology Dep. Not yet recruiting Balıkesir, Turkey Contact: Ayla Yıldız Savaş drmssa@gmail.com Gaziantep Şahinbey Research and Training Hospital Gastroenterology Dep. Not yet recruiting Gaziantep, Turkey Contact: Abdullah Emre Yıldırım, Assoc Prof Dr draemreyildirim@gmail.com Dr. Sadi Konuk Research and Training Hospital Gastroenterology Dep. Not yet recruiting Istanbul, Turkey Contact: Aliye Soylu, Prof Dr aliyesoylu@superonline.com Ümraniye Research and Training Hospital Gastroenterology Dep. Not yet recruiting Istanbul, Turkey Contact: Zuhal Çalışkan, Assoc Prof Dr caliskanzuhal@gmail.com Ege University Medical Faculty Gastroenterology Dep. Not yet recruiting İzmir, Turkey Contact: Serhat Bor, Prof Dr serhatbor@yahoo.com Tepecik Research and Training Hospital Gastroenterology Dep. Not yet recruiting İzmir, Turkey Contact: Betül Paköz, MD betulpakoz@yahoo.com Celal Bayar University Medical Faculty Gastroenterology Dep. Not yet recruiting Manisa, Turkey Contact: Elmas Kasap, Assoc Prof Dr elmaskasap@yahoo.com Sıtkı Koçman University Medical Faculty Gastroenterology Dep. Not yet recruiting Muğla, Turkey Contact: Burak Özşeker, Assoc Prof Dr burakozseker@gmail.com Recep Tayyip Erdoğan University Medical Faculty Gastroenterology Dep. Not yet recruiting Rize, Turkey Contact: Remzi Adnan Akdoğan, Assoc Prof Dr remziadnan@yahoo.com Cumhuriyet University Medical Faculty Gastroenterology Dep. Not yet recruiting Sivas, Turkey Contact: Özlem Yönem, Prof Dr ozlemyonem@gmail.com Less << |
NCT03488186 | Effect of Drugs ... More >> Safety Issues Less << | Phase 1 | Not yet recruiting | December 2018 | China, Zhejiang ... More >> First affiliated hospital of Zhejiang University Hangzhou, Zhejiang, China, 310003 Less << |
NCT02541786 | Helicobacter Pylori Infection | Phase 4 | Completed | - | Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 807 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 813 Less << |
NCT01568944 | Chronic Periodontitis | Not Applicable | Completed | - | United States, Georgia ... More >> GHSU-CDM Clinical Research Center Augusta, Georgia, United States, 30912 Less << |
NCT03316976 | Healthy Volunteers | PHASE1 | COMPLETED | 2018-02-08 | Phase I Clinical Trial Departm... More >>ent, Beijing, Beijing, 100005, China Less << |
NCT01149395 | Heartburn|Gastroesophageal Ref... More >>lux Disease Less << | PHASE1 | COMPLETED | 2025-04-12 | University of North Carolina a... More >>t Chapel Hill, Chapel Hill, North Carolina, 27599, United States Less << |
NCT02096458 | Gastroesophageal Reflux Diseas... More >>e|Erosive Esophagitis|Heartburn Less << | PHASE1 | COMPLETED | 2025-02-14 | Woburn, Massachusetts, 01801, ... More >>United States Less << |
NCT02616302 | Gastroesophageal Reflux Diseas... More >>e (GERD) Less << | PHASE2 | RECRUITING | 2027-10-31 | University of South Alabama, M... More >>obile, Alabama, 36604, United States|University of California San Francisco, San Francisco, California, 94158, United States|D&H National Research Centers, Miami, Florida, 33155, United States|Children's Center for Digestive Health Care, LLC, Atlanta, Georgia, 30342, United States|Gastrointestinal Associates, PA, Flowood, Mississippi, 39232, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, 44106, United States|Measurable Outcome Research, Oklahoma City, Oklahoma, 73112, United States|GI for Kids, Knoxville, Tennessee, 37922, United States|Vanderbilt University Medical Center, Nashville, Tennessee, 37212, United States|Envision Clinical Research, LLC, Laredo, Texas, 78041, United States|The Children's Hospital of The King's Daughters, Norfolk, Virginia, 23507, United States|Women and Children's Health Research Institute, Edmonton, Alberta, T6G 1C9, Canada|London Health Sciences Centre (LHSC) - Children's Hospital, London, Ontario, N6A 5W9, Canada|Hospital Universitario San Ignacio, Bogota, 110231, Colombia|Fundacion Valle del Lili, Cali, 760032, Colombia|Centro Medico Imbanaco de Cali S.A, Cali, 760042, Colombia|Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas, LT-50161, Lithuania|Children's Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Public Institution, Vilnius, LT-08661, Lithuania|Boca Clinical Trials Mexico SC, Colonia Las Americas, Distrito Federal, 1120, Mexico|Clinical Research Institute S.C., Tlalnepantla, Estado De Mexico, 54055, Mexico|Inspirepharma S. de R.L. de C.V., Monterrey, Nuevo Leon, 64660, Mexico|El Cielo Medical Center, Puebla, 72160, Mexico|SMIQ S. de R.L. de C.V., Queretaro, 76070, Mexico|In Vivo Osrodek Badan Klinicznych, Bydgoszcz, Kuyavia, 85-048, Poland|Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Malopolskie, 30-663, Poland|Instytut "Pomnik - Centrum Zdrowia Dziecka", Warszawa, Masovia, 04-730, Poland|Gabinet Lekarski Bartosz Korczowski, Rzeszow, Podkarpackie, 35-302, Poland Less << |
NCT01642602 | Gastroesophageal Reflux Diseas... More >>e Less << | PHASE2 | COMPLETED | 2025-01-14 | Huntsville, Alabama, United St... More >>ates|Mobile, Alabama, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Anaheim, California, United States|Los Angeles, California, United States|San Francsco, California, United States|Centennial, Colorado, United States|Thornton, Colorado, United States|Miami, Florida, United States|Atlanta, Georgia, United States|Chicago, Illinois, United States|Park Ridge, Illinois, United States|Indianapolis, Indiana, United States|Louisville, Kentucky, United States|Boston, Massachusetts, United States|Flint, Michigan, United States|Plymouth, Minnesota, United States|Jackson, Mississippi, United States|Kansas City, Missouri, United States|Mays Landing, New Jersey, United States|Brooklyn, New York, United States|Huntsville, North Carolina, United States|Toledo, Ohio, United States|Youngstown, Ohio, United States|Greenville, South Carolina, United States|Kingsport, Tennessee, United States|Ft. Worth, Texas, United States|Houston, Texas, United States|Laredo, Texas, United States|San Antonio, Texas, United States|Ogden, Utah, United States|Salt Lake City, Utah, United States|Fairfax, Virginia, United States|Norfolk, Virginia, United States|Bruxelles, Belgium|Passo Fundo, Rio Grande do Sul, Brazil|Porto Alegre, Rio Grande do Sul, Brazil|Santo Andre, Sao Paulo, Brazil|Santo André, Sao Paulo, Brazil|S?o José do Rio Preto, Sao Paulo, Brazil|Debrecen, Hungary|Gy?r, Hungary|Miskolc, Hungary|Nyiregyhaza, Hungary|Pecs, Hungary|Veszprem, Hungary|Bari, Italy|Messina, Italy|Roma, Italy|Mexico, Distrito Federal, Mexico|Monterrey, Nuevo León, Mexico|Culiacan, Sinaloa, Mexico|Bydgoszcz, Poland|Krakow, Poland|Rzeszow, Poland|Szczecin, Poland|Torun, Poland|Warszawa, Poland|Wroclaw, Poland|Amadora, Portugal|Braga, Portugal|Coimbra, Portugal|Lisboa, Portugal|Porto, Portugal Less << |
NCT00928161 | Head and Neck Cancer|Oropharyn... More >>geal Cancer|Gastroesophageal Reflux Disease Less << | WITHDRAWN | - | - | |
NCT01328392 | Laryngo-pharyngeal Reflux | WITHDRAWN | 2025-04-12 | University of Washington, Seat... More >>tle, Washington, 98105, United States Less << | |
NCT02351960 | Gastroesophageal Reflux Diseas... More >>e Less << | PHASE4 | COMPLETED | 2016-07-13 | Shatin, New Territories, Hong ... More >>Kong|Gyeonggi-do, 463-707, Korea, Republic of|Gyeonggi-do, Korea, Republic of|Seoul, 137-701, Korea, Republic of|Seoul, Korea, Republic of|Kaoshiung, Taiwan|Taichung, Taiwan|Tainan, Taiwan|Taipei, Taiwan|Taoyuan, Taiwan Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.71mL 0.54mL 0.27mL |
13.54mL 2.71mL 1.35mL |
27.07mL 5.41mL 2.71mL |
|
Dissolving Methods |
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
|